These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1973684)

  • 1. The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.
    Olerup O; Schaffer M; Hillert J; Sachs C
    Immunogenetics; 1990; 32(1):41-4. PubMed ID: 1973684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
    Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
    Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients.
    Zeliszewski D; Tiercy JM; Boitard C; Gu XF; Loche M; Krishnamoorthy R; Simonney N; Elion J; Bach JF; Mach B
    Hum Immunol; 1992 Feb; 33(2):140-7. PubMed ID: 1348743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-D-region genomic DNA restriction fragments in DRw15 (DR2) familial narcolepsy.
    Ditta SD; George CF; Singh SM
    Sleep; 1992 Feb; 15(1):48-57. PubMed ID: 1348374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis is associated with genes within or close to the HLA-DR-DQ subregion on a normal DR15,DQ6,Dw2 haplotype.
    Hillert J; Olerup O
    Neurology; 1993 Jan; 43(1):163-8. PubMed ID: 8093808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA restriction fragment length polymorphism of HLA-DR2 haplotypes in normal individuals and in patients with rheumatoid arthritis.
    Singal DP; Reid B; Green D; Bensen WG; D'Souza M
    Ann Rheum Dis; 1990 Mar; 49(3):143-6. PubMed ID: 1969727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR restriction-fragment-length polymorphisms in narcolepsy.
    Holloman JD; Bell JI; Kilduff TS; Dement WC; Guilleminault C; McDevitt HO
    J Neurosci Res; 1987; 18(1):239-44. PubMed ID: 2890770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsy and HLA in the Japanese.
    Juji T; Matsuki K; Tokunaga K; Naohara T; Honda Y
    Ann N Y Acad Sci; 1988; 540():106-14. PubMed ID: 2905117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
    Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
    Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.
    Kagnoff MF; Harwood JI; Bugawan TL; Erlich HA
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6274-8. PubMed ID: 2788285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ?
    Francis DA; Thompson AJ; Brookes P; Davey N; Lechler RI; McDonald WI; Batchelor JR
    Hum Immunol; 1991 Oct; 32(2):119-24. PubMed ID: 1683865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR and -DQ genotyping in anti-GBM disease.
    Dunckley H; Chapman JR; Burke J; Charlesworth J; Hayes J; Haywood E; Hutchison B; Ibels L; Kalowski S; Kincaid-Smith P
    Dis Markers; 1991; 9(5):249-56. PubMed ID: 1686749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQA, -DQB and -DRB allele contribution to narcolepsy susceptibility.
    Planelles D; Puig N; Beneto A; Gomez E; Rubio P; Mirabet V; Bonanad S; Blasco I; Montoro JA
    Eur J Immunogenet; 1997 Dec; 24(6):409-21. PubMed ID: 9534039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
    Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
    Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy.
    Honda Y; Juji T; Matsuki K; Naohara T; Satake M; Inoko H; Someya T; Harada S; Doi Y
    Sleep; 1986; 9(1 Pt 2):133-42. PubMed ID: 3010426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA polymorphism of HLA class II genes in systemic lupus erythematosus.
    Cowland JB; Andersen V; Halberg P; Morling N
    Tissue Antigens; 1994 Jan; 43(1):34-7. PubMed ID: 7912858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction fragment length polymorphism analysis of HLA-DR- and DQ-linked alleles in multiple sclerosis in Spain.
    Clerici N; Fernández M
    J Neuroimmunol; 1992 Dec; 41(2):245-8. PubMed ID: 1361490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction fragment length polymorphism of HLA-DQ and -DR allogenotypes in normal southern Chinese.
    Li PK; Poon AS; Hawkins BR; Yeung VT; Bo YH; Lai KN
    Tissue Antigens; 1993 Nov; 42(5):502-8. PubMed ID: 7908466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.